Dr. Marylène Genta

Dr. Marylène Genta is a senior consultant ophthalmologist and vitreoretinal surgeon at the Princess Grace Hospital Centre (CHPG) in Monaco, where she has led the ophthalmology and retinal surgery service for over 20 years. She is one of the most experienced retinal specialists on the French Riviera, with a particular focus on the medical and surgical management of age-related macular degeneration (AMD), diabetic eye disease, retinal detachment, and cataract surgery.

Dr. Genta completed her medical studies at the Université de Paris VI Pierre et Marie Curie before undertaking her ophthalmology residency at the Hôpital des Quinze-Vingts in Paris — France's national ophthalmology hospital and the country's leading centre for retinal and anterior segment diseases. She subsequently completed a subspecialty fellowship in vitreoretinal surgery at the Moorfields Eye Hospital in London, one of the world's premier eye hospitals, gaining advanced training in retinal detachment surgery, macular surgery, and vitreoretinal trauma management. This training at two of Europe's foremost eye hospitals gave Dr. Genta an exceptional foundation in both medical retina and complex surgical techniques.

At the CHPG, Dr. Genta runs a busy intravitreal injection clinic managing patients with AMD, diabetic macular oedema, and retinal vein occlusions on anti-VEGF therapy, which has become the mainstay of treatment for these conditions in the modern era. She also performs phacoemulsification cataract surgery, vitrectomy for retinal detachment and macular conditions, and laser photocoagulation for proliferative diabetic retinopathy.

Dr. Genta has a strong interest in telemedicine applications for diabetic eye disease screening, recognising that Monaco and the French Riviera's population — with its high prevalence of Type 2 diabetes driven by affluent lifestyle factors — requires efficient and accessible retinal screening pathways. She has developed a telemedicine-assisted diabetic retinopathy screening programme in collaboration with local diabetologists at CHPG.

Dr. Genta earned her medical degree from the Université Paris VI Pierre et Marie Curie (now Sorbonne Université), Faculty of Medicine. She undertook her ophthalmology specialty residency at the Hôpital National des Quinze-Vingts in Paris — France's national ophthalmology reference hospital — gaining comprehensive training in anterior and posterior segment diseases, surgical and medical ophthalmology, and low vision rehabilitation. She completed a vitreoretinal surgery fellowship at Moorfields Eye Hospital in London, working with internationally recognised vitreoretinal surgeons and gaining expertise in complex retinal detachment repair, macular hole surgery, epiretinal membrane peeling, and vitreoretinal trauma. She holds the Fellow of the European Board of Ophthalmology (FEBO) designation, awarded by the European Board of Ophthalmology following examination of specialist-level competency across the breadth of ophthalmological practice. She maintains active membership of EURETINA and participates in annual retinal specialist congresses to stay at the forefront of evolving anti-VEGF therapy protocols and retinal surgical techniques.

Dr. Genta's primary clinical expertise lies in medical and surgical retinal disease. In age-related macular degeneration, she manages both dry and wet (neovascular) AMD, with expertise in treatment decisions, anti-VEGF injection scheduling (ranibizumab, aflibercept, bevacizumab), and monitoring of treatment response using optical coherence tomography (OCT) and OCT angiography. She manages patients on treat-and-extend and pro re nata (PRN) protocols, tailoring injection frequency to individual disease activity.

For diabetic retinopathy, Dr. Genta provides both laser photocoagulation for proliferative disease and intravitreal anti-VEGF therapy for diabetic macular oedema. She runs the CHPG diabetic eye screening clinic and coordinates with the endocrinology team to integrate retinal screening into the broader management of diabetic patients.

In surgical ophthalmology, Dr. Genta performs phacoemulsification cataract surgery including combined cataract and vitreoretinal procedures. Her vitreoretinal surgical repertoire includes primary retinal detachment repair (vitrectomy and scleral buckling), macular hole surgery, epiretinal membrane peeling, vitreous haemorrhage clearance, and surgical management of proliferative vitreoretinopathy (PVR). She also assesses and manages glaucoma using topical therapy and laser trabeculoplasty.

Dr. Genta has published over 50 peer-reviewed articles in ophthalmology journals including Ophthalmology, Retina, the British Journal of Ophthalmology, and Graefe's Archive for Clinical and Experimental Ophthalmology. Her primary research areas include anti-VEGF therapy outcomes in neovascular AMD, long-term safety and efficacy of intravitreal injection programmes in a Mediterranean outpatient setting, and the use of telemedicine for diabetic retinopathy screening. Her work on telemedicine-assisted screening for diabetic eye disease in the CHPG Monaco population has been presented at EURETINA congresses and has contributed to advocacy for broader adoption of teleophthalmology in European specialist settings. She is also a co-investigator on a multicentre study examining treat-and-extend anti-VEGF protocols in AMD coordinated through the SFO. She received the SFO Young Researcher Award early in her career, recognising the quality and originality of her retinal research.

Dr. Genta regularly treats international patients at CHPG Monaco, reflecting the Principality's large expatriate and international visitor population. She conducts consultations in French, Italian, and English, enabling direct communication with the majority of patients visiting from across Europe and internationally. CHPG's ophthalmology department is equipped with state-of-the-art diagnostic imaging equipment including OCT, OCT angiography, fluorescein angiography, and visual field testing. EU residents can access her services under EHIC or S2 cross-border healthcare authorisations. Non-EU international patients are accommodated through CHPG's international patient services. For patients who travel from outside Monaco for complex retinal surgery or second-opinion consultations, coordination of pre- and post-operative follow-up with their home country eye specialists can be arranged.

Dr. Genta received the Société Française d'Ophtalmologie (SFO) Young Researcher Award in recognition of her early contributions to retinal disease research and anti-VEGF outcomes science. The Princess Grace Hospital Centre awarded her the Clinical Innovation Prize for her development of the CHPG telemedicine-assisted diabetic retinopathy screening programme, which has expanded access to retinal screening in Monaco's diabetic patient population. She holds the Fellow of the European Board of Ophthalmology (FEBO) designation and is a member of EURETINA, serving on the society's education committee. She has been invited to present at EURETINA, SFO, and Moorfields alumni symposia, and her work is cited in European guidelines on diabetic eye disease screening.